Phospho-MAPKAPK-2 (Thr334) Antibody (Rabbit mAb) [J17A19] Datasheet

Biological Description

Specificity	Phospho-MAPKAPK-2 (Thr334) Antibody (Rabbit mAb) [J17A19] detects endogenous levels of total MAPKAPK-2 protein only when it is phosphorylated at Thr334.
Background	MAPKAPK-2, also designated MK2, belongs to the CAMK serine/threonine kinase family and functions as a direct downstream substrate of p38alpha MAPK, forming a physiological complex with p38alpha that resides in the nucleus of resting cells prior to stimulation. MK2 carries an N-terminal proline-rich region connected to a catalytic kinase domain, followed by a C-terminal regulatory domain containing a bipartite nuclear localization signal and a nuclear export signal, with the crystal structure of unphosphorylated MK2 showing this C-terminal region folding into a helix-turn-helix plus an extended strand that packs against the kinase domain in an autoinhibited configuration. Upon activation, p38alpha phosphorylates MK2 at three sites required for full kinase activity, threonine 222 within the activation loop, serine 272, and threonine 334, which is positioned between the kinase domain and the C-terminal regulatory domain; structural analysis of the p38alpha-MK2 heterodimer shows the two kinases bound head-to-head with their active sites on the same face of the complex, and the MK2 segment containing the nuclear export signal directly blocks access to the p38alpha active site in the unphosphorylated state. Phosphorylation at Thr334 specifically functions as a conformational switch rather than simply completing kinase activation: it weakens or interrupts the packing of the C-terminal regulatory domain against the catalytic domain, unmasking the nuclear export signal that was previously buried along the kinase domain's C-lobe surface, and this exposed export signal engages the leptomycin B-sensitive nuclear export receptor to carry both MK2 and its bound p38alpha out of the nucleus into the cytoplasm. This Thr334-dependent nuclear export requires the phosphorylation event itself but does not require MK2's catalytic activity, meaning the phosphorylation acts as a structural switch independent of substrate turnover, and because p38alpha lacks its own nuclear export signal, it depends entirely on complex formation with phosphorylated MK2 to relocate to the cytoplasm. Once exported, cytoplasmic active MK2 phosphorylates downstream effectors including HSP27, tristetraprolin, and other targets that regulate cytoskeletal dynamics and mRNA stability during the inflammatory response, coupling nuclear p38 activation to a defined cytoplasmic phosphorylation program through this single Thr334-controlled relocalization event.

Specificity

Phospho-MAPKAPK-2 (Thr334) Antibody (Rabbit mAb) [J17A19] detects endogenous levels of total MAPKAPK-2 protein only when it is phosphorylated at Thr334.

Background

MAPKAPK-2, also designated MK2, belongs to the CAMK serine/threonine kinase family and functions as a direct downstream substrate of p38alpha MAPK, forming a physiological complex with p38alpha that resides in the nucleus of resting cells prior to stimulation. MK2 carries an N-terminal proline-rich region connected to a catalytic kinase domain, followed by a C-terminal regulatory domain containing a bipartite nuclear localization signal and a nuclear export signal, with the crystal structure of unphosphorylated MK2 showing this C-terminal region folding into a helix-turn-helix plus an extended strand that packs against the kinase domain in an autoinhibited configuration. Upon activation, p38alpha phosphorylates MK2 at three sites required for full kinase activity, threonine 222 within the activation loop, serine 272, and threonine 334, which is positioned between the kinase domain and the C-terminal regulatory domain; structural analysis of the p38alpha-MK2 heterodimer shows the two kinases bound head-to-head with their active sites on the same face of the complex, and the MK2 segment containing the nuclear export signal directly blocks access to the p38alpha active site in the unphosphorylated state. Phosphorylation at Thr334 specifically functions as a conformational switch rather than simply completing kinase activation: it weakens or interrupts the packing of the C-terminal regulatory domain against the catalytic domain, unmasking the nuclear export signal that was previously buried along the kinase domain's C-lobe surface, and this exposed export signal engages the leptomycin B-sensitive nuclear export receptor to carry both MK2 and its bound p38alpha out of the nucleus into the cytoplasm. This Thr334-dependent nuclear export requires the phosphorylation event itself but does not require MK2's catalytic activity, meaning the phosphorylation acts as a structural switch independent of substrate turnover, and because p38alpha lacks its own nuclear export signal, it depends entirely on complex formation with phosphorylated MK2 to relocate to the cytoplasm. Once exported, cytoplasmic active MK2 phosphorylates downstream effectors including HSP27, tristetraprolin, and other targets that regulate cytoskeletal dynamics and mRNA stability during the inflammatory response, coupling nuclear p38 activation to a defined cytoplasmic phosphorylation program through this single Thr334-controlled relocalization event.

Usage Information

Application

WB

Dilution

WB

1:1000

Reactivity

Human, Mouse, Rat, Monkey

Source

Rabbit Monoclonal Antibody

MW

46 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

References

https://pubmed.ncbi.nlm.nih.gov/12171911/
https://pubmed.ncbi.nlm.nih.gov/17395714/

Phospho-MAPKAPK-2 (Thr334) Antibody (Rabbit mAb) [J17A19]

Biological Description

Usage Information

References

Application Data